| Prospective comparison of 18F-fluoromethylcholine versus 68Ga-PSMA PET/CT in prostate cancer patients who have rising PSA after curative treatment and are being considered for … JJ Morigi, PD Stricker, PJ van Leeuwen, R Tang, B Ho, Q Nguyen, ... Journal of nuclear medicine 56 (8), 1185-1190, 2015 | 631 | 2015 |
| A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer I Cagiannos, P Karakiewicz, JA Eastham, M Ohori, F Rabbani, C Gerigk, ... The Journal of urology 170 (5), 1798-1803, 2003 | 476 | 2003 |
| Frequent loss of estrogen receptor-β expression in prostate cancer LG Horvath, SM Henshall, CS Lee, DR Head, DI Quinn, S Makela, ... Cancer research 61 (14), 5331-5335, 2001 | 418 | 2001 |
| The impact of 68Ga-PSMA PET/CT on management intent in prostate cancer: results of an Australian prospective multicenter study PJ Roach, R Francis, L Emmett, E Hsiao, A Kneebone, G Hruby, T Eade, ... Journal of Nuclear Medicine 59 (1), 82-88, 2018 | 368 | 2018 |
| Prognostic impact of positive surgical margins in surgically treated prostate cancer: multi-institutional assessment of 5831 patients PI Karakiewicz, JA Eastham, M Graefen, I Cagiannos, PD Stricker, E Klein, ... Urology 66 (6), 1245-1250, 2005 | 340 | 2005 |
| Quality of life three years after diagnosis of localised prostate cancer: population based cohort study DP Smith, MT King, S Egger, MP Berry, PD Stricker, P Cozzi, J Ward, ... Bmj 339, 2009 | 329 | 2009 |
| Prospective evaluation of 68Gallium‐prostate‐specific membrane antigen positron emission tomography/computed tomography for preoperative lymph node staging in prostate cancer PJ van Leeuwen, L Emmett, B Ho, W Delprado, F Ting, Q Nguyen, ... BJU international 119 (2), 209-215, 2017 | 317 | 2017 |
| Growth factor involvement in progression of prostate cancer PJ Russell, S Bennett, P Stricker Clinical chemistry 44 (4), 705-723, 1998 | 316 | 1998 |
| 68Ga‐PSMA has a high detection rate of prostate cancer recurrence outside the prostatic fossa in patients being considered for salvage radiation treatment PJ van Leeuwen, P Stricker, G Hruby, A Kneebone, F Ting, B Thompson, ... BJU international 117 (5), 732-739, 2016 | 311 | 2016 |
| Survival analysis of genome-wide gene expression profiles of prostate cancers identifies new prognostic targets of disease relapse SM Henshall, DEH Afar, J Hiller, LG Horvath, DI Quinn, KK Rasiah, K Gish, ... Cancer research 63 (14), 4196-4203, 2003 | 293 | 2003 |
| Multiparametric magnetic resonance imaging guided diagnostic biopsy detects significant prostate cancer and could reduce unnecessary biopsies and over detection: a prospective … JE Thompson, D Moses, R Shnier, P Brenner, W Delprado, L Ponsky, ... The Journal of urology 192 (1), 67-74, 2014 | 271 | 2014 |
| Altered expression of androgen receptor in the malignant epithelium and adjacent stroma is associated with early relapse in prostate cancer SM Henshall, DI Quinn, CS Lee, DR Head, D Golovsky, PC Brenner, ... Cancer research 61 (2), 423-427, 2001 | 257 | 2001 |
| International validation of a preoperative nomogram for prostate cancer recurrence after radical prostatectomy M Graefen, PI Karakiewicz, I Cagiannos, DI Quinn, SM Henshall, ... Journal of clinical oncology 20 (15), 3206-3212, 2002 | 252 | 2002 |
| The additive diagnostic value of prostate-specific membrane antigen positron emission tomography computed tomography to multiparametric magnetic resonance imaging triage in the … L Emmett, J Buteau, N Papa, D Moon, J Thompson, MJ Roberts, K Rasiah, ... European urology 80 (6), 682-689, 2021 | 230 | 2021 |
| EAU-EANM-ESTRO-ESUR-SIOG prostate cancer guideline panel consensus statements for deferred treatment with curative intent for localised prostate cancer from an international … TBL Lam, S MacLennan, PPM Willemse, MD Mason, K Plass, R Shepherd, ... European urology 76 (6), 790-813, 2019 | 211 | 2019 |
| The role of magnetic resonance imaging in the diagnosis and management of prostate cancer J Thompson, N Lawrentschuk, M Frydenberg, L Thompson, P Stricker, ... BJU international 112, 6-20, 2013 | 194 | 2013 |
| The propeptide mediates formation of stromal stores of PROMIC-1: role in determining prostate cancer outcome AR Bauskin, DA Brown, S Junankar, KK Rasiah, S Eggleton, M Hunter, ... Cancer research 65 (6), 2330-2336, 2005 | 193 | 2005 |
| Superior quality of life and improved surgical margins are achievable with robotic radical prostatectomy after a long learning curve: a prospective single-surgeon study of 1552 … JE Thompson, S Egger, M Böhm, AM Haynes, J Matthews, K Rasiah, ... European urology 65 (3), 521-531, 2014 | 192 | 2014 |
| Global levels of specific histone modifications and an epigenetic gene signature predict prostate cancer progression and development T Bianco-Miotto, K Chiam, G Buchanan, S Jindal, TK Day, M Thomas, ... Cancer epidemiology, biomarkers & prévention 19 (10), 2611-2622, 2010 | 190 | 2010 |
| Treatment outcomes from 68Ga-PSMA PET/CT–informed salvage radiation treatment in men with rising PSA after radical prostatectomy: prognostic value of a negative PSMA PET L Emmett, PJ van Leeuwen, R Nandurkar, MJ Scheltema, T Cusick, ... Journal of Nuclear Medicine 58 (12), 1972-1976, 2017 | 183 | 2017 |
